AMY SIPLE, ARNP
Nurse Practitioner in WICHITA, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
AMY SIPLE, ARNP filed 173 Medicare Part D claims in 2023 as a Nurse Practitioner in WICHITA, Kansas, prescribing 90% generic.
- 173
- Part D claims, 2023
- 90%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
AMY SIPLE, ARNP's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
173 35th percentile higher than 35% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about AMY SIPLE, ARNP?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Kansas
How Nurse Practitioner compares to other specialties among Kansas providers
Nurse Practitioner share within Kansas
Nurse Practitioner is one of the more visible NUCC categories in Kansas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Nurse Practitioner (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Nurse Practitioner ABMS/AOA estimate
Est. board-certified rate (Nurse Practitioner) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Nurse Practitioner US NPIs
Specialty board-certified rate — Nurse Practitioner estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
AMY SIPLE, ARNP appears in the CMS NPPES registry as a Nurse Practitioner provider holding ARNP credentials at 347 S LAURA ST, WICHITA, KS, 67211, with a listed phone of (316) 686-7117. NPI 1235189986 was issued on 05/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SIPLE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 173 prescription claims written by this provider, covering 15 Medicare beneficiaries and totaling roughly $13K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Nurse Practitioner is a high-volume specialty nationwide, with 87,227 enrolled providers across 56 states and an average of 1,084 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1235189986 |
|---|---|
| Specialty | Nurse Practitioner |
| Credentials | ARNP |
| Gender | Female |
| NPI Issued | 05/12/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm AMY SIPLE, ARNP's current license status, disciplinary history, and board certifications with the Kansas Board of Healing Arts in Kansas before relying on this page for a clinical or care decision.
How we sourced this profile
Brand vs generic prescribing mix · Typical
10% brand-name claims vs 90% generic, on 173 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 173
- Total Day Supply
- 4,719
- Brand vs Generic
- 10% brand / 90% generic
- Brand Drug Cost
- $4K
- Generic Drug Cost
- $9K
Patient Demographics
- Average Patient Age
- 81.9 years
- Avg HCC Risk Score
- 1.76
- Age Distribution
- <65: 0, 65-74: N/A, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What AMY SIPLE, ARNP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Escitalopram Oxalate
Escitalopram Oxalate
24 claims
- Famotidine
Famotidine
13 claims
- Levothyroxine Sodium
Levothyroxine Sodium
13 claims
- Losartan Potassium
Losartan Potassium
13 claims
- Methenamine Hippur…
Methenamine Hippurate
13 claims
- Mirtazapine
Mirtazapine
13 claims
- Paliperidone Er
Paliperidone Er
13 claims
- Quetiapine Fumarate
Quetiapine Fumarate
13 claims
| Drug | Claims |
|---|---|
| Escitalopram Oxalate | 24 |
| Famotidine | 13 |
| Levothyroxine Sodium | 13 |
| Losartan Potassium | 13 |
| Methenamine Hippurate | 13 |
| Mirtazapine | 13 |
| Paliperidone Er Paliperidone | 13 |
| Quetiapine Fumarate | 13 |
| Amlodipine Besylate | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nurse Practitioner Overview
How AMY SIPLE, ARNP fits within the Nurse Practitioner landscape nationally.
AMY SIPLE, ARNP's 173 claims are below the specialty average of 1,084.
Nearby Nurse Practitioner Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as SIPLE.
Compare Nurse Practitioner nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Kansas
Frequently Asked Questions
What is AMY SIPLE, ARNP's specialty? ▼
How much does AMY SIPLE, ARNP prescribe under Medicare Part D? ▼
Where is AMY SIPLE, ARNP located? ▼
What is AMY SIPLE, ARNP's NPI number? ▼
Does AMY SIPLE, ARNP prescribe more brand-name or generic drugs? ▼
How many Nurse Practitioner providers are there in the US? ▼
What drugs does AMY SIPLE, ARNP prescribe most often? ▼
Does AMY SIPLE, ARNP accept Medicare? ▼
How can I verify AMY SIPLE, ARNP's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology